<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examined a possible association between the mutations related to Factor V Leiden and Factor II (prothrombin) and <z:hpo ids='HP_0001297'>stroke</z:hpo> in Saudi neonates </plain></SENT>
<SENT sid="1" pm="."><plain>A multiplex PCR was established to detect Factor V Leiden G1691A and prothrombin G20210A mutations in 72 neonatal <z:hpo ids='HP_0001297'>stroke</z:hpo> subjects and 70 healthy adult controls with no family history of <z:hpo ids='HP_0001907'>thromboembolic diseases</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The frequency of the homozygous <z:mpath ids='MPATH_458'>normal</z:mpath> genotype (GG) of both genes was found to be significantly lower in the <z:hpo ids='HP_0001297'>stroke</z:hpo> subjects than in the controls (P &lt; 0.0001) </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:hpo ids='HP_0001297'>stroke</z:hpo> cases also had higher frequencies of the combined Factor II heterozygous mutant form (GA) and the homozygous <z:mpath ids='MPATH_458'>normal</z:mpath> Factor V (GG) (P &lt; 0.0001) and of the combined heterozygous Factor V and the homozygous <z:mpath ids='MPATH_458'>normal</z:mpath> Factor II genotypes (GG) (P = 0.0) than controls </plain></SENT>
<SENT sid="4" pm="."><plain>The study concluded that prothrombin and Factor V Leiden may be important risk factors for neonatal <z:hpo ids='HP_0001297'>stroke</z:hpo> in Saudi children </plain></SENT>
</text></document>